Primary Job Title Chief Medical Officer Primary Organization 
WellMetris
Location Keego Harbor, Michigan, United States Regions Greater Detroit Area, Great Lakes, Midwestern US Gender Male
LinkedIn View on LinkedIn
Dr. Freeman is a drug development consultant for biotechnology and pharmaceutical companies. Dr. Freeman served as Vice President of Clinical Development at Onyx Pharmaceutical (2001-2006) and was head of both clinical development and operations, which executed the clinical trials for renal cell, melanoma, liver, lung, and colorectal cancer. The
Phase 1, 2, and 3 trials in kidney and liver cancer were successfully performed and led to NDA approval of Nexavar.
As Clinical Project Director at Schering-Plough Research Institute (1998-2001), his clinical projects included Phase 1, 2, and 3 trials for an anti-estrogen program, a breast cancer treatment, and a P53 gene therapy program.
He was Associate Professor at Tulane University (1992-1998) and also served as the Medical Director for the Tulane Blood Center.
Dr. Freeman has published sixty-four scientific papers. Dr. Freeman earned his B.A. from the University of Colorado in 1978 and received his MD from the University of Nevada in 1983. Dr. Freeman completed an internship and residency at the University of Minnesota in pediatrics and clinical pathology, respectively.
